10.04.2021
Prevent & Delay
$693,372.00
84 months
GPPAD Biobank - SINT1A
Funds will support a biobank of samples from the Supplementation with b. INfantis for mitigation of Type 1 diabetes Autoimmunity (SINT1A) trial, in partnership with investigators from the Global Platform for the Prevention of Autoimmune Diabetes.